B Group, Inc. Diversified Active

Location: Dallas, TX

CIK: 0002043476 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $135M (100.0% shares, 0.0% debt)

Holdings (16)

ADMA ADMA BIOLOGICS INC 33.1%

Value $44.83M Shares 2,457,542 Est. Cost $18.69 Unrealized -9.8%

CLLS CELLECTIS S A 11.7%

Value $15.88M Shares 3,281,501 Est. Cost $1.77 Unrealized —

PALI PALISADE BIO INC 7.8%

Value $10.57M Shares 4,500,000 Est. Cost $1.92 Unrealized 0.0%

TSHA TAYSHA GENE THERAPIES INC 7.3%

Value $9.903M Shares 1,800,556 Est. Cost $2.04 Unrealized +138.1%

PRAX PRAXIS PRECISION MEDICINES I 7.2%

Value $9.796M Shares 33,237 Est. Cost $58.36 Unrealized +219.1%

SGHT SIGHT SCIENCES INC 5.4%

Value $7.296M Shares 920,000 Est. Cost $4.05 Unrealized +57.9%

ZLAB ZAI LAB LTD 5.2%

Value $7.056M Shares 400,000 Est. Cost $26.19 Unrealized —

GPCR STRUCTURE THERAPEUTICS INC 4.6%

Value $6.26M Shares 90,000 Est. Cost $69.55 Unrealized —

ASMB ASSEMBLY BIOSCIENCES INC 4.4%

Value $5.976M Shares 175,706 Est. Cost $13.84 Unrealized +132.7%

IOVA IOVANCE BIOTHERAPEUTICS INC 3.0%

Value $4.095M Shares 1,500,000 Est. Cost $7.88 Unrealized -70.6%

SYRE SPYRE THERAPEUTICS INC 2.4%

Value $3.276M Shares 100,000 Est. Cost $23.56 Unrealized +10.9%

AURA AURA BIOSCIENCES INC 2.3%

Value $3.121M Shares 572,576 Est. Cost $8.79 Unrealized -32.4%

RARE ULTRAGENYX PHARMACEUTICAL IN 2.3%

Value $3.105M Shares 135,000 Est. Cost $37.33 Unrealized -11.9%

ORKA ORUKA THERAPEUTICS INC 1.7%

Value $2.273M Shares 75,000 Est. Cost $15.19 Unrealized +83.4%

APGE APOGEE THERAPEUTICS INC 1.1%

Value $1.51M Shares 20,000 Est. Cost $43.86 Unrealized +43.6%

REPL REPLIMUNE GROUP INC 0.4%

Value $486K Shares 50,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ADMA	ADMA BIOLOGICS INC	2,457,542	$44.83M	33.1%	$18.69	-9.8%	COM	000899104
CLLS	CELLECTIS S A	3,281,501	$15.88M	11.7%	$1.77	—	SPON ADS	15117K103
PALI	PALISADE BIO INC	4,500,000	$10.57M	7.8%	$1.92	0.0%	COM	696389402
TSHA	TAYSHA GENE THERAPIES INC	1,800,556	$9.903M	7.3%	$2.04	+138.1%	COM SHS	877619106
PRAX	PRAXIS PRECISION MEDICINES I	33,237	$9.796M	7.2%	$58.36	+219.1%	COM NEW	74006W207
SGHT	SIGHT SCIENCES INC	920,000	$7.296M	5.4%	$4.05	+57.9%	COM	82657M105
ZLAB	ZAI LAB LTD	400,000	$7.056M	5.2%	$26.19	—	ADR	98887Q104
GPCR	STRUCTURE THERAPEUTICS INC	90,000	$6.26M	4.6%	$69.55	—	SPONSORED ADS	86366E106
ASMB	ASSEMBLY BIOSCIENCES INC	175,706	$5.976M	4.4%	$13.84	+132.7%	COM NEW	045396207
IOVA	IOVANCE BIOTHERAPEUTICS INC	1,500,000	$4.095M	3.0%	$7.88	-70.6%	COM	462260100
SYRE	SPYRE THERAPEUTICS INC	100,000	$3.276M	2.4%	$23.56	+10.9%	COM NEW	00773J202
AURA	AURA BIOSCIENCES INC	572,576	$3.121M	2.3%	$8.79	-32.4%	COM	05153U107
RARE	ULTRAGENYX PHARMACEUTICAL IN	135,000	$3.105M	2.3%	$37.33	-11.9%	COM	90400D108
ORKA	ORUKA THERAPEUTICS INC	75,000	$2.273M	1.7%	$15.19	+83.4%	COM	687604108
APGE	APOGEE THERAPEUTICS INC	20,000	$1.51M	1.1%	$43.86	+43.6%	COM	03770N101
REPL	REPLIMUNE GROUP INC	50,000	$486K	0.4%	—	—	Call	76029N106